Autologous stem cell transplantation improves quality of life in economically challenged, brazilian multiple myeloma patients [PDF]
Clinics, 2011 OBJECTIVES: 1) To characterize the impact of multiple myeloma on the quality of life of patients treated in two public institutions in São Paulo State, Brazil, using a generic Short Form 36 Health Survey and a questionnaire specific for oncologic ...
Leina Y Etto +9 more
doaj +6 more sources
Challenging complications of treatment – human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case report [PDF]
Virology Journal, 2009 Background Reactivation of human herpesvirus 6 (HHV-6) occurs frequently in patients after allogeneic stem cell transplantation and is associated with bone-marrow suppression, enteritis, pneumonitis, pericarditis and also encephalitis.
Pauls Sandra +2 more
doaj +5 more sources
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma [PDF]
New England Journal of Medicine, 2018 Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem-cell transplantation with immunosuppression by means of 12 monthly infusions of cyclophosphamide in patients with scleroderma.We randomly assigned adults (18 to 69 years of
Jonathan G. Goldin +42 more
openaire +7 more sources
Analysis of the Efficacy of Autologous Peripheral Blood Stem Cell Transplantation in High-Risk Neuroblastoma [PDF]
, 2022 Objective: This study aimed to analyze the efficacy of autologous peripheral blood stem cell transplantation for high-risk neuroblastoma in China.
Benfu, Zhong +10 more
core +3 more sources
A survey on cellular and engineered tissue therapies in Europe in 2008 [PDF]
, 2010 Cellular therapy is an evolving investigational treatment modality in regenerative medicine, but little published information is available on its current use.
Baldomero, Helen +4 more
core +1 more source
a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma [PDF]
, 2016 Background Despite novel therapeutic agents, most multiple myeloma (MM) patients eventually relapse. Two large phase III trials have shown significantly improved response rates (RR) of lenalidomide/dexamethasone compared with placebo/dexamethasone in ...
Baertsch, Marc-Andrea +28 more
core +1 more source
Concise Review: The Potential Use of Intestinal Stem Cells to Treat Patients With Intestinal Failure. [PDF]
, 2016 : Intestinal failure is a rare life-threatening condition that results in the inability to maintain normal growth and hydration status by enteral nutrition alone.
Dunn, James CY +3 more
core +1 more source
Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: Increasingly successful application to older patients [PDF]
, 2016 Non-Hodgkin lymphoma (NHL) constitutes a collection of lymphoproliferative disorders with widely varying biological, histological, and clinical features.
Bredeson, Christopher +9 more
core +2 more sources
Quality of Life and psychopathology in adults who underwent Hematopoietic Stem Cell Transplantation (HSCT) in childhood: a qualitative and quantitative analysis. [PDF]
, 2017 Background: Patients who undergo pediatric Hematopoietic Stem Cell Transplantation (HSCT) may experience long-term psychological sequelae and poor Quality of Life (QoL) in adulthood. This study aimed to investigate subjective illness experience, QoL, and
Basso, G. +13 more
core +2 more sources
Autologous Stem Cell Transplantation and Multiple Myeloma Cancer Stem Cells [PDF]
Biology of Blood and Marrow Transplantation, 2012 It is well established that high-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) produces superior response rates and progression-free survival compared with conventional chemotherapy in patients with multiple myeloma (MM). Accordingly, MM currently represents the most common indication for ASCT.
Constantine S. Mitsiades +2 more
openaire +3 more sources